Palena, Claudia
National Cancer Institute
3 papers on CoChatORCID 0000-0002-0445-4486
Most cited papers
- Verified
Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models
Greene, S., Robbins, Y., Mydlarz, W. K., Huynh, A. P., Schmitt, N. C., Friedman, J., Horn, L. A., Palena, C., Schlom, J., Maeda, D. Y., et al. (2020) · Clinical Cancer Research
Immune cells in cancerImmune Cell Function and Interaction
Cited by 280
- Verified
Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances
Lind, H., Gameiro, S. R., Jochems, C., Donahue, R. N., Strauss, J., Gulley, J. L., Palena, C., & Schlom, J. (2020) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersTGF-β signaling in diseases
Cited by 247
- Verified
A novel bifunctional anti-PD-L1/TGF-β Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells
David, J. M., Dominguez, C., McCampbell, K. K., Gulley, J. L., Schlom, J., & Palena, C. (2017) · OncoImmunology
TGF-β signaling in diseasesCancer Immunotherapy and Biomarkers
Cited by 180
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free